HIGH ANTI-TNF ALFA DRUGS TROUGH LEVELS ARE NOT ASSOCIATED WITH THE OCCURRENCE OF ADVERSE EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引:0
|
作者
Bodini, G. [1 ]
Demarzo, G. [1 ]
Saracco, M. [1 ]
Coppo, C. [1 ]
De Maria, C. [1 ]
Baldissarro, I. [1 ]
Savarino, E. [2 ]
Savarino, V. [1 ]
Giannini, E. [1 ]
机构
[1] Univ Genoa, Policlin San Martino, Genoa, Italy
[2] Univ Padua, Padua, Italy
关键词
D O I
10.1016/S1590-8658(19)30453-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P.07.4
引用
收藏
页码:E223 / E223
页数:1
相关论文
共 50 条
  • [1] High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease
    Bodini, Giorgia
    Demarzo, Maria Giulia
    Saracco, Margherita
    Coppo, Claudia
    De Maria, Costanza
    Baldissarro, Isabella
    Savarino, Edoardo
    Savarino, Vincenzo
    Giannini, Edoardo G.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (10) : 1220 - 1225
  • [2] HIGH ANTI-TNF DRUGS TROUGH LEVELS ARE NOT ASSOCIATED WITH THE OCCURRENCE OF ADVERSE EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Bodini, Giorgia
    Demarzo, Maria Giulia
    Saracco, Margherita
    Coppo, Claudia
    Baldissarro, Isabella
    Jain, Anjali
    Savarino, Edoardo
    Savarino, Vincenzo
    Giannini, Edoardo G.
    GASTROENTEROLOGY, 2018, 154 (06) : S367 - S367
  • [3] High anti-TNF drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseases
    Bodini, G.
    Demarzo, M. G.
    Saracco, M.
    Coppo, C.
    Baldissarro, I.
    Anjali, J.
    Savarino, E.
    Savarino, V.
    Giannini, E.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S226 - S227
  • [4] High anti-TNFα Concentrations Are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease
    Zvuloni, Maya
    Matar, Manar
    Levi, Rachel
    Shouval, Dror S.
    Shamir, Raanan
    Assa, Amit
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 73 (06): : 717 - 721
  • [5] ADVERSE EVENTS IN ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS MANAGED WITH ANTI-TNF THERAPY
    Winters, Conchubhair
    Mooney, Peter
    GUT, 2018, 67 : A101 - A101
  • [6] Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
    Salvador-Martin, Sara
    Pujol-Muncunill, Gemma
    Bossacoma, Ferran
    Manuel Navas-Lopez, Victor
    Gallego-Fernandez, Carmen
    Segarra, Oscar
    Clemente, Susana
    Munoz-Codoceo, Rosana
    Viada, Javier
    Magallares, Lorena
    Martinez-Ojinaga, Eva
    Moreno-Alvarez, Ana
    Solar-Boga, Alfonso
    Loverdos, Ines
    Merino-Bohorquez, Vicente
    Jesus Balboa-Vega, Maria
    Rodriguez-Martinez, Alejandro
    Alvarez-Vayo, Concepcion
    Sanchez, Cesar
    Tolin, Mar
    Antonio Blanca-Garcia, Jose
    Garcia-Ronnero, Ruth
    Javier Eizaguirre, Francisco
    German Sanchez-Hernandez, Jose
    Gonzalez de Caldas, Rafael
    Millan-Jinnenez, Antonio
    Aznal, Elena
    Abarca-Zabalia, Judith
    Sanjurjo-Saez, Maria
    Andres Lopez-Fernandez, Luis
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (02) : 447 - 457
  • [7] Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
    Miheller, Pal
    Kiss, Lajos Sandor
    Lorinczy, Katalin
    Lakatos, Peter Laszlo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (02) : 179 - 192
  • [8] Inflammatory bowel disease after anti-TNF drugs
    Hamilton, Louise
    Griffin, Jane
    Dahiya, Sandeep
    Somerville, Margaret
    Stodell, Malcolm
    RHEUMATOLOGY, 2008, 47 : II18 - II18
  • [9] ADVERSE EVENTS ASSOCIATED WITH ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE COHORT GROUP IN A CROATIAN TERTIARY CENTRE
    Fric, V. Orsic
    Mimica-Matanovic, S.
    Borzan, V.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E114 - E115
  • [10] Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease
    Shivaji, Uday N.
    Sharratt, Caroline L.
    Thomas, Tom
    Smith, Samuel C. L.
    Iacucci, Marietta
    Moran, Gordon W.
    Ghosh, Subrata
    Bhala, Neeraj
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (06) : 664 - 680